HEMO Invest ApS: Financial statements 2023
CVR: 38403125
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
HEMO Invest ApS (CVR 38403125) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -61,839 and a net result of DKK 1,477,442 compared with DKK -3,069,301 the year before. Equity in the 2023 report amounted to DKK 28,303,756. The solvency ratio was 99.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -61,839
- Profit/Loss
- DKK 1,477,442
- Equity
- DKK 28,303,756
- Total Assets
- DKK 28,363,442
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -62K | 1.5M | 28.3M | 1 |
| 2022 | - | -29K | -3.1M | 27.6M | - |
| 2021 | - | -55K | 17.2M | 30.8M | - |
| 2020 | - | -43K | 8.9M | 13.7M | - |
| 2019 | - | -18K | 1.1M | 5M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
HEMO Invest ApS has published its annual report for 2022. Gross profit came to DKK -29,114, and the net result was DKK -3,069,301.
As of June 28, 2023, EY Godkendt Revisionspartnerselskab has stepped down as auditor of HEMO Invest ApS.
About HEMO Invest ApS
HEMO Invest ApS is a Danish company of the type Anpartsselskab based in Juelsminde, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Henrik Mortensen. The company is owned by Henrik Mortensen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -31,106 and a net result of DKK 527,412 compared with DKK 2,192,878 the year before. Equity in the 2025 report amounted to DKK 29,897,046.
